Management of sinonasal tumors may be challenging due to the complex anatomy of the sinonasal region and proximity to critical neurovascular structures. Furthermore, due to the rarity of these tumor types, treatment guidelines and recommendations may be difficult to define. As such, a multidisciplinary, international consortium of experts has convened to develop an international consensus statement on sinonasal tumors (ICSNT). There are 30 topics in the consensus statement, which were developed by an editorial team, and expert authors from all over the world were invited to perform systematic or literature reviews. In addition, the statement includes an Executive Summary and detailed description of the methods, which followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Evidence-based reviews (EBR) or evidence-based reviews with recommendations (EBRR) were developed and underwent iterative reviews by two associate editors until consensus was achieved. Topics included epidemiology, diagnostic workup, imaging, pathology, surgical approaches and complications, adjuvant therapies, prognosis, quality of life, and surveillance. This panel will be comprised of the editors and associate editors of this consensus statement, and highlights from the statement will be discussed. We will focus on general principles related to sinonasal oncology, such as resectability, management of the orbit, and margin analysis, and on benign sinonasal tumors, including vascular lesions, papillomas, orbital masses, and other rare benign neoplasms. Summaries and recommendations, when appropriate, for specific tumor types will be addressed. These guidelines will be highly relevant for otolaryngologists as they manage patients with sinonasal tumors. Finally, research and future directions for treatment of benign sinonasal tumors will be discussed.